These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22207318)

  • 41. Transdermal hormone replacement therapy with nanostructured medicines.
    Abdi F; Darooneh T; Ghorbani M; Banihashemi F; Roozbeh N
    Ginekol Pol; 2017; 88(2):103-108. PubMed ID: 28326520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review.
    Files J; Kling JM
    Expert Opin Drug Deliv; 2020 Apr; 17(4):543-549. PubMed ID: 31795776
    [No Abstract]   [Full Text] [Related]  

  • 43. Risks of hormone therapy in the 50-59 year age group.
    van de Weijer PH
    Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.
    Fugh-Berman A; McDonald CP; Bell AM; Bethards EC; Scialli AR
    PLoS Med; 2011 Mar; 8(3):e1000425. PubMed ID: 21423581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current attitudes on self-use and prescription of hormone therapy among New York City gynaecologists.
    Devi G; Sugiguchi F; Pedersen AT; Abrassart D; Glodowski M; Nachtigall L
    Menopause Int; 2013 Sep; 19(3):121-6. PubMed ID: 23761315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Turbulent times for hormone replacement therapy: is there a way out?
    Verhaeghe J
    Gynecol Obstet Invest; 2003; 56(1):43-50. PubMed ID: 12876424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
    Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
    Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.
    Harman SM; Vittinghoff E; Brinton EA; Budoff MJ; Cedars MI; Lobo RA; Merriam GR; Miller VM; Naftolin F; Pal L; Santoro N; Taylor HS; Black DM
    Am J Med; 2011 Mar; 124(3):199-205. PubMed ID: 21396500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen.
    Modena MG; Bursi F; Fantini G; Cagnacci A; Carbonieri A; Fortuna A; Rossi R
    Am J Med; 2002 Sep; 113(4):331-4. PubMed ID: 12361820
    [No Abstract]   [Full Text] [Related]  

  • 53. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005.
    Islam S; Liu Q; Chines A; Helzner E
    Menopause; 2009; 16(1):77-83. PubMed ID: 18703983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
    Grimes DA; Lobo RA
    Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study.
    Files JA; Miller VM; Cha SS; Pruthi S
    J Womens Health (Larchmt); 2014 Oct; 23(10):801-5. PubMed ID: 25268853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormone-replacement therapy: current thinking.
    Lobo RA
    Nat Rev Endocrinol; 2017 Apr; 13(4):220-231. PubMed ID: 27716751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Future long-term trials of postmenopausal hormone replacement therapy - what is possible and what is the optimal protocol and regimen?
    Purbrick B; Stranks K; Sum C; MacLennan AH
    Climacteric; 2012 Jun; 15(3):288-93. PubMed ID: 22612617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discontinuation rates of menopausal hormone therapy among postmenopausal women in the post-WHI study era.
    Kyvernitakis I; Kostev K; Hars O; Albert US; Hadji P
    Climacteric; 2015 Oct; 18(5):737-42. PubMed ID: 25845443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.